Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Outperforms Pathologists in Diagnosing Breast Cancer

By HospiMedica International staff writers
Posted on 20 Dec 2017
A study comparing the ability of Artificial Intelligence (AI) algorithms with expert pathologists in detecting metastatic breast cancer in whole-slide images found that the machine learning outperformed the pathologists. More...
The results of the study published in the Journal of the American Medical Association suggests that deep learning algorithms have the ability to improve diagnosis and could be used to help clinicians detect cancer in the clinic.

The study pitted 11 pathologists with time constraints and one pathologist without time constraints against seven deep learning algorithms in analyzing a training data set of whole-slide images – 110 with and 160 without verified nodal metastases. Out of the 49 test slides with metastatic disease, the pathologists found 31 on an average, while the pathologist allowed to work without time constraint correctly identified 46 out of 49 slides with cancer and 79 out of 80 slides without cancer.

Among the seven deep learning algorithms, the best algorithm performed significantly better in the whole-slide image classification task as compared to the pathologists working with time constraints. The mean performance of the top five algorithms was comparable with that of the single pathologist working without time constraints. However, at a mean of 0.0125 false-positives per normal whole-slide image, the performance of the best-performing algorithm was comparable with that of the single pathologist working without time constraint.

The research was led by Babak Ehteshami Bejnordi, Radboud University Medical Centre Nijmegen in the Netherlands. The researchers concluded that while the findings suggested the potential utility of deep learning algorithms for pathological diagnosis, it required further assessment in a clinical setting.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.